New research from King's College London has revealed a connection between ancient viral DNA embedded in the human genome and ...

Amyotrophic lateral sclerosis is a neurodegenerative disease characterised by selective degeneration of motor neurons. This ...

The study identified which specific HERVs are important in increasing susceptibility for neurodegenerative diseases.

A promising ALS drug may help combat glioblastoma by targeting the cancerous stem cells that fuel tumor growth.

TOKYO, Oct 16, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment ...

Oditrasertib, which blocks the inflammatory RIPK1 protein, earlier this year also failed a Phase II trial in amyotrophic ...

Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to ...

TOKYO, Oct 16, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection 25 mg” (mecobalamin) has received the ...

Hall, founder of Beacon of Hope for ALS, aims to lift people up and help them after their diagnosis. Amyotrophic lateral ...

The Speech Accessibility Project is now recruiting Canadian adults with Parkinson’s disease, cerebral palsy, amyotrophic lateral sclerosis, Down syndrome and those who have had a stroke.